Startseite Kongressberichte 2020 ESMO VIRTUAL 2020 SARS-CoV-2 & Cancer Proffered Paper - SARS-CoV-2 and cancer 1

Proffered Paper - SARS-CoV-2 and cancer 1

LINK to Proffered Paper - SARS-CoV-2 and cancer 1

LINK to STREAM (needs an ESMO registration)

LBA69 - Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients

The abstract concludes: Lockdown due to COVID-19 induced tt modification in 1/4 of pts with a majored post-traumatic stress. Despite a high level of stress, caregivers coped with the situation.


LBA70_PR - The impact of COVID-19 on oncology professionals: Initial results of the ESMO resilience task force survey collaboration

The abstract concludes: In the largest global survey series, COVID-19 is impacting on the wellbeing and job performance of oncology professionals. Risk of distress and burnout has increased over time. Urgent measures to address wellbeing and improve resilience are essential.

Impact of COVID-19 on oncology professionals Watch now >  (ecancer video)
Dr Susana Banerjee
The Royal Marsden NHS Foundation Trust, London, UK

Read also ESMO's Daily Reporter News:

How is COVID-19 Affecting the Wellbeing of Oncology Professionals?


LBA71 - Systemic cancer treatment-related outcomes in patients with SARS-CoV-2 infection: A CCC19 registry analysis

The abstract concludes: 30-day mortality was highest amongst cancer pts treated 1-3 months prior to COVID-19 diagnosis and those treated with chemoimmunotherapy. Except for endocrine therapy, mortality for subgroups was numerically higher than in pts untreated within a year prior to COVID-19 diagnosis.


1670O - Prospective data of first 1,797 hospitalised patients with cancer and COVID-19 derived from the COVID-19 Clinical Information Network and international Severe Acute Respiratory and emerging Infections Consortium, WHO Coronavirus Clinical Characterisation Consortium

The abstract concludes: Europe’s largest prospective COVID-19 dataset demonstrates that cancer is independently associated with mortality in patients admitted with COVID-19. Data collection is on-going and updated data will be presented including a comparison of cancer vs. non-cancer cohort with regard to presentation, comorbidity and otucomes.

Read also ESMO's Daily Reporter News: 

How Does COVID-19 Impact on the Prognosis of Patients With Cancer?